People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nuclein, LLC | — | Biotechnology | Series A | $34.5M | $48.3M | 2019 |
Alan Blake at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Alan Blake on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sanjay Chandra | 1 | 11 |
| John Butler | 1 | 5 |
| William Cunningham | 1 | 3 |
| H. David Shockley | 1 | 2 |
| Jeffrey David Stukuls | 1 | 1 |
| Walter Narajowski | 1 | 1 |
| David Shockley | 1 | 1 |
| Richard Crockett | 1 | 1 |
| Douglas Bryant | 1 | 1 |
| Walter David Narajowski | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.